
Windlas
WINDLAS.NSWindlas Biotech Limited Price (WINDLAS.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
20,872,745
(3.5274)%Description
Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers who market such products under their own brand names to the end users. It also offers manufactures various domestic trade generics and over-the-counter brand pr... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $495.65-1198.25
- Market Cap 19.37B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - Specialty & Generic
- ceo: Ms. Komal Gupta
- IPO Date: August, 16, 2021
- Country: IN
- Currency: INR
- Headquaters: No Data
- Employees: 1154
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
